Kissel JT, Mendell JR, Rammohen KW: Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 314:329, 1986.
Kishani PS, Corzo D, Nicolino M, et al: Recombinant human a-glucosidase. Major clinical benefits in infantile-onset Pompe disease. Neurology 68:99, 2007.
Kodama K, Sikorska H, Bandy-Dafoe P, et al: Demonstration of circulating autoantibody against a soluble eye-muscle antigen in Graves’ ophthalmopathy. Lancet 2:1353, 1982.
Kono N, Mineo I, Sumi S, et al: Metabolic basis of improved exercise tolerance: Muscle phosphorylase deficiency after glucagon administration. Neurology 34:1471, 1984.
Krahn M, de Munain AL, Streichenberger N, et al: CAPN3 mutations in patients with idiopathic eosinophilic myositis. Ann Neurol 59:905, 2006.
Krasnianski M, Eger K, Neudeckers S, et al: Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion. Arch Neurol 60:1421, 2003.
Kugelberg E, Welander L: Heredofamilial juvenile muscular atrophy simulating muscular dystrophy. Arch Neurol Psychiatry 75:500, 1956.
Kuhn E, Fiehn W, Schroder JM, et al: Early myocardial disease and cramping myalgia in Becker type muscular dystrophy: A kindred. Neurology 29:1144, 1979.
Kuncl RW, Duncan G, Watson D, et al: Colchicine myopathy and neuropathy. N Engl J Med 316:1562, 1987.
Kunkel LM: Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature 322:73, 1986.
Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ: Acute myopathy of intensive care: Clinical, electromyographic, and pathological aspects. Ann Neurol 40:645, 1996.
Layzer RB: Neuromuscular Manifestations of Systemic Disease. Philadelphia, Davis, 1985.
Layzer RB, Rowland LP, Ranney HM: Muscle phosphofructokinase deficiency. Arch Neurol 17:512, 1967.
Layzer RB, Shearn MA, Satya-Murti S: Eosinophilic polymyositis. Ann Neurol 1:65, 1977.
Lebenthal E, Shochet SR, Adam A, et al: Arthrogryposis multiplex congenita: 23 cases in an Arab kindred. Pediatrics 46:891, 1970.
Lennon N, Kho A, Bacskai BJ, et al: Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound healing. J Biol Chem 278(50):50466, 2003.
Lodi R, Taylor DJ, Tabrizi SJ, et al: Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy. Brain 121:2119, 1998.